Welty, Timothy E. Chapman, Kevin E. Faught, R. Edward Kotloski, Robert J. Supplemental Material, 03-Appendix_A-2019-07-16-American_Epilepsy_Society-FDA_Comments-CBD - American Epilepsy Society (AES): Written Comments to Norman E. “Ned” Sharpless, MD, Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA), Department of Health and Human Services (HHS): on Docket ID# FDA-2019-N-1482, <i>Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments</i>: Submitted on: July 16, 2019 <p>Supplemental Material, 03-Appendix_A-2019-07-16-American_Epilepsy_Society-FDA_Comments-CBD for American Epilepsy Society (AES): Written Comments to Norman E. “Ned” Sharpless, MD, Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA), Department of Health and Human Services (HHS): on Docket ID# FDA-2019-N-1482, <i>Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments</i>: Submitted on: July 16, 2019 by Timothy E. Welty, Kevin E. Chapman, R. Edward Faught and Robert J. Kotloski in Epilepsy Currents</p> AES;Products Containing Cannabis;Drug Administration;U.S;FDA -2019-N Scientific Data;1 Kevin Chapman;HHS;American Epilepsy Society;ID;Comment;MD;comment 2019-11-04
    https://sage.figshare.com/articles/journal_contribution/Supplemental_Material_03-Appendix_A-2019-07-16-American_Epilepsy_Society-FDA_Comments-CBD_-_American_Epilepsy_Society_AES_Written_Comments_to_Norman_E_Ned_Sharpless_MD_Acting_Commissioner_of_Food_and_Drugs_U_S_Food_and_Drug_Administration_F/10033421
10.25384/SAGE.10033421.v2